An inhibitory alternative splice isoform of Toll-like receptor 3 is induced by type I interferons in human astrocyte cell lines
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Toll-like receptor 3 (TLR3) recognizes viral double-stranded RNA. It stimulates pro-inflammatory cytokine and interferon production. Here we reported the expression of a novel isoform of TLR3 in human astrocyte cell lines whose message is generated by alternative splicing. The isoform represents the N-terminus of the protein. It lacks many of the leucine-rich repeat domains, the transmembrane domain, and the intracellular Toll/interleukin-1 receptor domain of TLR3. Type I interferons (interferon- and interferon-) induced the expression of this isoform. Exogenous overexpression of this isoform inhibited interferon regulatory factor 3, signal transducers and activators of transcription 1, and Inhibitor of kappa B signaling following stimulation. This isoform of TLR3 also inhibited the production of chemokine interferon--inducible protein 10. Our study clearly demonstrated that the expression of this isoform of TLR3 was a negative regulator of signaling pathways and that it was inducible by type I interferons. We also found that this isoform could modulate inflammation in the brain.
Abstract
Toll-like receptor 3 (TLR3) recognizes viral double-stranded RNA. It stimulates pro-inflammatory cytokine and interferon production. Here we reported the expression of a novel isoform of TLR3 in human astrocyte cell lines whose message is generated by alternative splicing. The isoform represents the N-terminus of the protein. It lacks many of the leucine-rich repeat domains, the transmembrane domain, and the intracellular Toll/interleukin-1 receptor domain of TLR3. Type I interferons (interferon- and interferon-) induced the expression of this isoform. Exogenous overexpression of this isoform inhibited interferon regulatory factor 3, signal transducers and activators of transcription 1, and Inhibitor of kappa B signaling following stimulation. This isoform of TLR3 also inhibited the production of chemokine interferon--inducible protein 10. Our study clearly demonstrated that the expression of this isoform of TLR3 was a negative regulator of signaling pathways and that it was inducible by type I interferons. We also found that this isoform could modulate inflammation in the brain.
참고문헌 (32)
- Matsumoto M, "Antiviral responses induced by the TLR3 pathway", Rev Med Virol, 21, pp.67~77 (2011)
- Hosokawa Y, "TLR3 agonist enhances CC chemokine ligand 20production in IL-1beta-stimulated human gingival fibroblasts", Cell Immunol, 283, pp.8~11 (2013)
- Yu M, "Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses", Cytokine Growth Factor Rev, 22, pp.63~72 (2011)
- Farina C, "Preferential expression and function of Toll-like receptor 3 in human astrocytes", J Neuroimmunol, 159, pp.12~19 (2005)
- Olson JK, "Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs", J Immunol, 173, pp.3916~3924 (2004)
- Matsumoto M, "Subcellular localization of Toll-like receptor 3 in human dendritic cells", J Immunol, 171, pp.3154~3162 (2003)
- Town T, "Microglia recognize double-stranded RNA via TLR3", J Immunol, 176, pp.3804~3812 (2006)
- Suh HS, "Toll-like receptors in CNS viral infections", Curr Top Microbiol Immunol, 336, pp.63~81 (2009)
- Galic MA, "Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats", Neurobiol Dis, 36, pp.343~351 (2009)
- Riazi K, "Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability", Epilepsy Res, 89, pp.34~42 (2010)
- Dakovic I, "Clinical features of cerebral palsy in children with symptomatic congenital cytomegalovirus infection", Eur J Paediatr Neurol, 18, pp.618~623 (2014)
- Singh TD, "Postencephalitic epilepsy: clinical characteristics and predictors", Epilepsia, 56, pp.133~138 (2015)
- Wilson JC, "Previously diagnosed influenza infections and the risk of developing epilepsy", Epidemiol Infect, pp.1~8 (2014)
- Sofroniew MV, "Astrocytes : biology and pathology", Acta Neuropathol, 119, pp.7~35 (2010)
- Oanh Thi Tu Le, "Phosphoinositide turnover in Toll-like receptor signaling and trafficking", BMB Reports, 47(7), pp.361~368 (2014), 생화학분자생물학회
- Costello DA, "Toll-like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon-beta", Hippocampus, 23, pp.696~707 (2013)
- Pan LN, "Astrocytic Toll-like receptor 3 is associated with ischemic preconditioning-induced protection against brain ischemia in rodents", PLoS One, 9, pp.e99526~ (2014)
- Nakajima A, "Induction of interferon-induced transmembrane protein 3 gene expression by lipopolysaccharide in astrocytes", Eur J Pharmacol, 745, pp.166~175 (2014)
- Kim H, "Double-stranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging Toll-like receptor 3 in human brain astrocytes", Immunology, 124, pp.480~488 (2008)
- 양은정, "Cloning of TLR3 Isoform", Yonsei Medical Journal, 45(2), pp.359~361 (2004), 연세대학교의과대학
- Sepulveda FE, "Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells", Immunity, 31, pp.737~748 (2009)
- Marshak-Rothstein A, "Toll-like receptors in systemic autoimmune disease", Nat Rev Immunol, 6, pp.823~835 (2006)
- Krieg AM, "Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity", Immunol Rev, 220, pp.251~269 (2007)
- Chockalingam A, "Negative regulation of signaling by a soluble form of toll-like receptor 9", Eur J Immunol, 41, pp.2176~2184 (2011)
- Ewald SE, "Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase", J Exp Med, 208, pp.643~651 (2011)
- Manoury B, "TLR9 regulation by proteolysis: a friend or a foe", Eur J Immunol, 41, pp.2142~2144 (2011)
- Miranda-Hernandez S, "Role of toll-like receptors in multiple sclerosis", Am J Clin Exp Immunol, 2, pp.75~93 (2013)
- Touil T, "Cutting Edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta", J Immunol, 177, pp.7505~7509 (2006)
- Murakami Y, "Roles of the cleaved N-terminal TLR3 fragment and cell surface TLR3in double-stranded RNA sensing", J Immunol, 193, pp.5208~5217 (2014)
- Garcia-Cattaneo A, "Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling", Proc Natl Acad Sci U S A, 109, pp.9053~9058 (2012)
- Toscano F, "Cleaved", associated TLR3 represents the primary form of the signaling receptor, 2013, pp.190, 764~773
- Qi R, "Proteolytic processing regulates Toll-like receptor 3 stability and endosomal localization", J Biol Chem, 287, pp.32617~32629 (2012)